share_log

Mizuho Maintains Buy on CVS Health, Lowers Price Target to $72

Mizuho Maintains Buy on CVS Health, Lowers Price Target to $72

瑞穗維持對CVS Health的買入,將目標股價下調至72美元
Benzinga ·  05/02 07:45

Mizuho analyst Ann Hynes maintains CVS Health (NYSE:CVS) with a Buy and lowers the price target from $86 to $72.

瑞穗分析師安·海因斯維持CVS Health(紐約證券交易所代碼:CVS)的買入並將目標股價從86美元下調至72美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論